Report Overview:
The following report titled “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market: By Component (Software, Service), By Application (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research) and other forecast 2021-2026” provides a comprehensive analysis of the market, focusing on key details such as market size, growth trends, determinants of growth, segments covered, and the role of leading players in the industry.
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Summary
The “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market” is likely to grow at a CAGR of around 23.6% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth primarily attributes to the rising demand for reducing the cost of novel drug discovery and their production. Additionally, the adoption of artificial intelligence is significantly increasing, as faster, efficient, and cost-effective drug discovery is gaining momentum amongst the pharmaceutical industry stakeholders.
Report Coverage & Details
- Forecast Period: 2021-2026
- Base Year: 2021
- CAGR: 23.6%
“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”
Download Free PDF Brochure: – https://www.marknteladvisors.com/query/request-sample/artificial-intelligence-enabled-drug-discovery-clinical-trials.html
Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Driver:
Burgeoning technological advancements like AI, 4K Imaging, and IoT (Internet of Things) have resulted in surging the demand for integrating these high-end technologies in the healthcare industry. AI helps provide patient-centric treatment, better diagnostic services, and accurate decision-making, thereby recognizing errors in the current situations and providing better alternatives in complex scenarios. Hence, AI technology is likely to encourage the growth of the Drug Discovery and Clinical Trials Market.
Segmentation Analysis: Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market
By Application
- Data Aggregation and Analysis
- Clinical Trials
- Drug Design
- Drug Characterization
- Biomarker Research
By Therapeutic Application
- Oncology
- Cardiovascular Disease
- Nervous System Disease
- Respiratory Disorder
- Metabolic Disorder
- Immunologic Disease
- Infectious Disease
- Others
By End-User
- Biopharmaceutical Industry
- Contract Research Organization (CROs)
- Academic Institutes and Research Centers
By Region
- North America
- South America
- Europe
- Asia-Pacific
- Middle East & Africa
Access Full Report [Include Description + TOC] – https://www.marknteladvisors.com/research-library/artificial-intelligence-enabled-drug-discovery-clinical-trials.html
Leading Players Analysis: Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market
The report provides detailed analysis of key players in the global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials market, highlighting their strategies and competitive scenario.
- Accutar Biotechnology
- Ardigen
- Atomwise Inc.
- AiCure, LLC
- Berg LLc
- Cloud Pharmaceuticals
- Biovista
- Cyclica Inc.
- Symphony Innovations
- GNS Healthcare
Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.
For Customized Report Inquiry: – https://www.marknteladvisors.com/query/request-customization/artificial-intelligence-enabled-drug-discovery-clinical-trials.html
Key Benefits for Stakeholders:
- Informed Decision-Making: Access to comprehensive and insightful market research reports enables stakeholders to make well-informed decisions, leading to more strategic and successful initiatives.
- Strategic Planning: The strategic reports provided by MarkNtel Advisors empower stakeholders to formulate robust strategies for market entry, product development, and competitive positioning.
- Market Sizing & Forecasting: Stakeholders can benefit from accurate market sizing and forecasting data to make informed investment and resource allocation decisions, minimizing risks and maximizing returns.
- Competitive Benchmarking: The availability of competitive benchmarking data allows stakeholders to assess their performance against industry peers, identify areas for improvement, and capitalize on strengths.
- Identifying Investment Opportunities: Through trend analysis and industry insights, stakeholders can identify attractive investment opportunities and stay ahead in the market for better ROI.
About us
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, Saudi Arabia, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Information:
- Call (India): +91 120 4278433
- Call (USA): +1 628 895 8081
- Email: sales@marknteladvisors.com
- Website: MarkNtel Advisors: Market Research Company